Synopsis

Source of validity: Scientific
Rating (out of 5): 2

Bacillus species, particularly Bacillus subtilis and Bacillus coagulans, have been explored as probiotic alternatives to antibiotics, especially in the context of livestock and, to a lesser extent, human health. The scientific rationale is that certain Bacillus strains can modulate the gut microbiota, enhance immune responses, and secrete antimicrobial peptides (bacteriocins) that inhibit pathogenic bacteria. In animal agriculture, Bacillus-based probiotics are sometimes used to reduce antibiotic use by promoting gut health and preventing infections. In humans, some small-scale clinical studies and in vitro experiments suggest that Bacillus probiotics may reduce the risk of certain gastrointestinal infections and help restore the microbiome after antibiotic treatment. However, evidence supporting Bacillus as a direct alternative to antibiotics in treating infections is limited and primarily preclinical or animal-based. Major medical guidelines do not currently endorse Bacillus as a standalone alternative to antibiotics for treating infections in humans. Thus, while there is some scientific basis and growing research interest, the evidence remains modest and not yet robust enough for broad clinical application.

More about Bacillus (unspecified)
More about Antibiotics (alternatives to)

Other ingredients used for Antibiotics (alternatives to)

Other health conditions supported by Bacillus (unspecified)

Products containing Bacillus (unspecified)